Detalhe da pesquisa
1.
Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO.
Dermatol Ther (Heidelb)
; 14(5): 1327-1335, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649673
2.
Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO).
Front Med (Lausanne)
; 10: 1185523, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37457564
3.
The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination.
Sci Transl Med
; 14(655): eabn3041, 2022 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35679357
4.
Brain SPECT as an Imaging Biomarker for Evaluating Effects of Novel Treatments in Psychiatry-A Case Series.
Front Psychiatry
; 12: 713141, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35095582
5.
A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2.
Infect Dis Ther
; 10(4): 1933-1947, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374951
6.
Combination therapy with transcranial magnetic stimulation and ketamine for treatment-resistant depression: A long-term retrospective review of clinical use.
Heliyon
; 5(8): e02187, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31440588